These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 20725733)

  • 21. cGMP-stimulated cyclic nucleotide phosphodiesterase regulates the basal calcium current in human atrial myocytes.
    Rivet-Bastide M; Vandecasteele G; Hatem S; Verde I; Bénardeau A; Mercadier JJ; Fischmeister R
    J Clin Invest; 1997 Jun; 99(11):2710-8. PubMed ID: 9169501
    [TBL] [Abstract][Full Text] [Related]  

  • 22. PI3Kgamma is required for PDE4, not PDE3, activity in subcellular microdomains containing the sarcoplasmic reticular calcium ATPase in cardiomyocytes.
    Kerfant BG; Zhao D; Lorenzen-Schmidt I; Wilson LS; Cai S; Chen SR; Maurice DH; Backx PH
    Circ Res; 2007 Aug; 101(4):400-8. PubMed ID: 17615371
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Equilibrium between adenylyl cyclase and phosphodiesterase patterns adrenergic agonist dose-dependent spatiotemporal cAMP/protein kinase A activities in cardiomyocytes.
    De Arcangelis V; Liu S; Zhang D; Soto D; Xiang YK
    Mol Pharmacol; 2010 Sep; 78(3):340-9. PubMed ID: 20530128
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Challenge of human Jurkat T-cells with the adenylate cyclase activator forskolin elicits major changes in cAMP phosphodiesterase (PDE) expression by up-regulating PDE3 and inducing PDE4D1 and PDE4D2 splice variants as well as down-regulating a novel PDE4A splice variant.
    Erdogan S; Houslay MD
    Biochem J; 1997 Jan; 321 ( Pt 1)(Pt 1):165-75. PubMed ID: 9003416
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibition of platelet-derived growth factor-induced mitogenesis by phosphodiesterase 3 inhibitors: role of protein kinase A in vascular smooth muscle cell mitogenesis.
    Osinski MT; Schrör K
    Biochem Pharmacol; 2000 Aug; 60(3):381-7. PubMed ID: 10856433
    [TBL] [Abstract][Full Text] [Related]  

  • 26. beta-Arrestin-mediated PDE4 cAMP phosphodiesterase recruitment regulates beta-adrenoceptor switching from Gs to Gi.
    Baillie GS; Sood A; McPhee I; Gall I; Perry SJ; Lefkowitz RJ; Houslay MD
    Proc Natl Acad Sci U S A; 2003 Feb; 100(3):940-5. PubMed ID: 12552097
    [TBL] [Abstract][Full Text] [Related]  

  • 27. cAMP phosphodiesterase inhibitors potentiate effects of prostacyclin analogs in hypoxic pulmonary vascular remodeling.
    Phillips PG; Long L; Wilkins MR; Morrell NW
    Am J Physiol Lung Cell Mol Physiol; 2005 Jan; 288(1):L103-15. PubMed ID: 15377497
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Phosphodiesterase-4 influences the PKA phosphorylation status and membrane translocation of G-protein receptor kinase 2 (GRK2) in HEK-293beta2 cells and cardiac myocytes.
    Li X; Huston E; Lynch MJ; Houslay MD; Baillie GS
    Biochem J; 2006 Mar; 394(Pt 2):427-35. PubMed ID: 16356165
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Regulation of cAMP accumulation and activity by distinct phosphodiesterase subtypes in INS-1 cells and human pancreatic β-cells.
    Pratt EPS; Harvey KE; Salyer AE; Hockerman GH
    PLoS One; 2019; 14(8):e0215188. PubMed ID: 31442224
    [TBL] [Abstract][Full Text] [Related]  

  • 30. cAMP-specific phosphodiesterase HSPDE4D3 mutants which mimic activation and changes in rolipram inhibition triggered by protein kinase A phosphorylation of Ser-54: generation of a molecular model.
    Hoffmann R; Wilkinson IR; McCallum JF; Engels P; Houslay MD
    Biochem J; 1998 Jul; 333 ( Pt 1)(Pt 1):139-49. PubMed ID: 9639573
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hypoxia-induced remodelling of PDE4 isoform expression and cAMP handling in human pulmonary artery smooth muscle cells.
    Millen J; MacLean MR; Houslay MD
    Eur J Cell Biol; 2006 Jul; 85(7):679-91. PubMed ID: 16458997
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Activation and induction of cyclic AMP phosphodiesterase (PDE4) in rat pulmonary microvascular endothelial cells.
    Zhu B; Kelly J; Vemavarapu L; Thompson WJ; Strada SJ
    Biochem Pharmacol; 2004 Aug; 68(3):479-91. PubMed ID: 15242814
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cyclic AMP-mediated regulation of vascular smooth muscle cell cyclic AMP phosphodiesterase activity.
    Rose RJ; Liu H; Palmer D; Maurice DH
    Br J Pharmacol; 1997 Sep; 122(2):233-40. PubMed ID: 9313930
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Negative feedback exerted by cAMP-dependent protein kinase and cAMP phosphodiesterase on subsarcolemmal cAMP signals in intact cardiac myocytes: an in vivo study using adenovirus-mediated expression of CNG channels.
    Rochais F; Vandecasteele G; Lefebvre F; Lugnier C; Lum H; Mazet JL; Cooper DM; Fischmeister R
    J Biol Chem; 2004 Dec; 279(50):52095-105. PubMed ID: 15466415
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Formation of reactive oxygen metabolites in glomeruli is suppressed by inhibition of cAMP phosphodiesterase isozyme type IV.
    Chini CC; Chini EN; Williams JM; Matousovic K; Dousa TP
    Kidney Int; 1994 Jul; 46(1):28-36. PubMed ID: 7933846
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cyclic GMP regulation of the L-type Ca(2+) channel current in human atrial myocytes.
    Vandecasteele G; Verde I; Rücker-Martin C; Donzeau-Gouge P; Fischmeister R
    J Physiol; 2001 Jun; 533(Pt 2):329-40. PubMed ID: 11389195
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Phosphorylation and activation of a cAMP-specific phosphodiesterase by the cAMP-dependent protein kinase. Involvement of serine 54 in the enzyme activation.
    Sette C; Conti M
    J Biol Chem; 1996 Jul; 271(28):16526-34. PubMed ID: 8663227
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Phosphodiesterases 2, 3 and 4 can decrease cardiac effects of H
    Neumann J; Voss R; Laufs U; Werner C; Gergs U
    Naunyn Schmiedebergs Arch Pharmacol; 2021 Jun; 394(6):1215-1229. PubMed ID: 33576869
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Differential regulation of mesangial cell mitogenesis by cAMP phosphodiesterase isozymes 3 and 4.
    Cheng J; Thompson MA; Walker HJ; Gray CE; Diaz Encarnacion MM; Warner GM; Grande JP
    Am J Physiol Renal Physiol; 2004 Nov; 287(5):F940-53. PubMed ID: 15280158
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of the effects of cilostazol and milrinone on cAMP-PDE activity, intracellular cAMP and calcium in the heart.
    Shakur Y; Fong M; Hensley J; Cone J; Movsesian MA; Kambayashi J; Yoshitake M; Liu Y
    Cardiovasc Drugs Ther; 2002 Sep; 16(5):417-27. PubMed ID: 12652111
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.